Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Sep 13:4:13.
doi: 10.1186/1476-0711-4-13.

Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection

Seth D Crockett  1 , Emmet B Keeffe
Affiliations
Review

Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection

Seth D Crockett et al. Ann Clin Microbiol Antimicrob. .

Abstract

Hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection is not uncommon as a result of similar routes of infection. Patients who are coinfected represent a unique group with diverse serologic profiles. Combined chronic hepatitis B and C leads to more severe liver disease and an increased risk of hepatocellular carcinoma. Furthermore, coinfected patients represent a treatment challenge. No standard recommendations exist for treatment of viral hepatitis due to dual HBV/HCV infection, and therefore treatment must be individualized based on patient variables such as serologic and virologic profiles, patient's prior exposure to antiviral treatment, and the presence of other parenterally transmitted viruses such as hepatitis D virus and human immunodeficiency virus. The natural history and treatment of patients with HBV and HCV coinfection is reviewed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Infectious scenarios and treatment window for patients coinfected with hepatitis B and hepatitis C viruses. HBV = hepatitis B virus, HCV = hepatitis C virus.
See this image and copyright information in PMC

References

    1. Benvegnu L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cecchetto A, Alberti A. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer. 1994;74:2442–8. - PubMed
    1. Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer. 1999;85:2132–7. doi: 10.1002/(SICI)1097-0142(19990515)85:10<2132::AID-CNCR6>3.0.CO;2-H. - DOI - PubMed
    1. Weltman MD, Brotodihardjo A, Crewe EB, Farrell GC, Bilous M, Grierson JM, Liddle C. Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment. J Viral Hepat. 1995;2:39–45. - PubMed
    1. Kaklamani E, Trichopoulos D, Tzonou A, Zavitsanos X, Koumantaki Y, Hatzakis A, Hsieh CC, Hatziyannis S. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA. 1991;265:1974–6. doi: 10.1001/jama.265.15.1974. - DOI - PubMed
    1. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337:1733–45. doi: 10.1056/NEJM199712113372406. - DOI - PubMed

MeSH terms

LinkOut - more resources